NO972771L - Ny reseptor - Google Patents

Ny reseptor

Info

Publication number
NO972771L
NO972771L NO972771A NO972771A NO972771L NO 972771 L NO972771 L NO 972771L NO 972771 A NO972771 A NO 972771A NO 972771 A NO972771 A NO 972771A NO 972771 L NO972771 L NO 972771L
Authority
NO
Norway
Prior art keywords
binds
compound
tissue
brain tissue
rat
Prior art date
Application number
NO972771A
Other languages
English (en)
Other versions
NO972771D0 (no
Inventor
Hugh Jonathan Herdon
Jeffrey Clifford Jerman
Wai Ngor Chan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO972771D0 publication Critical patent/NO972771D0/no
Publication of NO972771L publication Critical patent/NO972771L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Det beskrives en reseptor i tilnærmet ren form, som kan oppnås fra vev fra rotte forhjerne, og som kjennetegnes ved at: a) Forbindelse A binder seg til den med en Kd på 40 nM for vev fra rotte-forhjerne, b) Forbindelse A binder seg til den med en Bpå 220 pmol/g protein for vev fra rotte-forhjerne, c) Forbindelse B binder seg til den med en Kd på 2 nM for vev fra rotte-forhjerne, d) Forbindelse B binder seg til den med en på 220 pmol/g protein for vev fra rotte-forhjerne; og homologe reseptorer fra andre kilder som har minst 85% homologi med vevet fra rotte-forhjerne.
NO972771A 1994-12-17 1997-06-16 Ny reseptor NO972771L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9425502.3A GB9425502D0 (en) 1994-12-17 1994-12-17 Novel receptor
PCT/EP1995/004998 WO1996018650A1 (en) 1994-12-17 1995-12-11 Novel receptor

Publications (2)

Publication Number Publication Date
NO972771D0 NO972771D0 (no) 1997-06-16
NO972771L true NO972771L (no) 1997-08-15

Family

ID=10766105

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972771A NO972771L (no) 1994-12-17 1997-06-16 Ny reseptor

Country Status (15)

Country Link
US (1) US5985334A (no)
EP (1) EP0807122A1 (no)
JP (1) JPH10511083A (no)
CN (1) CN1175262A (no)
AU (1) AU710150B2 (no)
BR (1) BR9510060A (no)
CA (1) CA2207921A1 (no)
CZ (1) CZ187697A3 (no)
FI (1) FI972558A0 (no)
GB (1) GB9425502D0 (no)
HU (1) HUT77077A (no)
NO (1) NO972771L (no)
NZ (1) NZ298059A (no)
PL (1) PL320747A1 (no)
WO (1) WO1996018650A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245893B1 (en) * 1994-12-17 2001-06-12 Smithkline Beecham P.L.C. Receptor that binds anti-convulsant compounds
CA3168730A1 (en) * 2020-03-10 2021-09-16 Heather BUCKLEY Light-activated pathogen-killing molecules and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
WO1995006117A1 (en) * 1993-08-20 1995-03-02 Smithkline Beecham Plc Human 5-ht2 receptor

Also Published As

Publication number Publication date
JPH10511083A (ja) 1998-10-27
US5985334A (en) 1999-11-16
CA2207921A1 (en) 1996-06-20
NO972771D0 (no) 1997-06-16
WO1996018650A1 (en) 1996-06-20
EP0807122A1 (en) 1997-11-19
BR9510060A (pt) 1998-06-02
NZ298059A (en) 2000-03-27
MX9704560A (es) 1997-10-31
AU4345896A (en) 1996-07-03
CN1175262A (zh) 1998-03-04
PL320747A1 (en) 1997-10-27
HUT77077A (hu) 1998-03-02
AU710150B2 (en) 1999-09-16
FI972558A7 (fi) 1997-06-16
FI972558L (fi) 1997-06-16
GB9425502D0 (en) 1995-02-15
FI972558A0 (fi) 1997-06-16
CZ187697A3 (en) 1997-10-15

Similar Documents

Publication Publication Date Title
BG103189A (en) Substituted 6,5-heterobicyclic derivatives
CA2278151A1 (en) Heregulin variants
DZ3482A1 (fr) Secretagogues de l'hormone de croissance
NL300808I1 (no)
DK1765860T3 (da) Ny-ESO-T.cellereceptor med höj affinitet
NO974270L (no) Insulinderivater
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
AUPO755097A0 (en) Receptor agonist and antagonist
DE69129302D1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
DE69942753D1 (de) Peptidantagonist von Zonulin und dessen Verwendung
IL221366A (en) Soluble zb7ri polypeptide and method used
TR200102338T2 (tr) Siklik ikame edilmiş bağlı pirolokarbazoller ve izoindolonlar.
DK0772603T3 (da) Substituerede pyrimidinforbindelser og deres anvendelse
KR970704438A (ko) 티아졸 및 티아디아졸 화합물의 D 도파민 수용체 리간드로서의 용도(Use of Thiazole and Thiadiazole Compounds as D Dopamine Receptor Ligands)
DK0754301T3 (da) Fremstilling og stabilisering af cellesuspensioner
CO5460266A1 (es) Novedosos analogos de la somatostatina
NO972771L (no) Ny reseptor
ATE408631T1 (de) Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion
DK0811058T3 (da) Fremgangsmåde til fremstilling af faktor IX ud fra biologiske kilder
ES2195033T3 (es) Iso-indolonas condensadas utilizadas como inhibidores de proteina quinasa c.
DE69929683D1 (de) Antisense modulierung von lfa-3
DE69939586D1 (de) Inhibitoren für die gefässneubildung
DE69924519D1 (de) Allo- und autoreaktive t-zell epitope von rhesus protein und deren verwendung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application